• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象受限的噌啉酮核苷类似物作为结核病铁载体生物合成抑制剂

Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis.

作者信息

Dawadi Surendra, Boshoff Helena I M, Park Sae Woong, Schnappinger Dirk, Aldrich Courtney C

机构信息

Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, United States.

出版信息

ACS Med Chem Lett. 2018 Mar 16;9(4):386-391. doi: 10.1021/acsmedchemlett.8b00090. eCollection 2018 Apr 12.

DOI:10.1021/acsmedchemlett.8b00090
PMID:29670706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5900334/
Abstract

5'--[-(Salicyl)sulfamoyl]adenosine (Sal-AMS, ) is a nucleoside antibiotic that inhibits incorporation of salicylate into siderophores required for bacterial iron acquisition and has potent activity against (). Cinnolone analogues exemplified by were designed to replace the acidic acyl-sulfamate functional group of (p = 3) by a more stable sulfonamide linkage (p = 6.0) in an attempt to address potential metabolic liabilities and improve membrane permeability. We showed potently inhibited the mycobacterial salicylate ligase MbtA (apparent = 12 nM), blocked production of the salicylate-capped siderophores in whole-cell , and exhibited excellent antimycobacterial activity under iron-deficient conditions (minimum inhibitor concentration, MIC = 2.3 μM). To provide additional confirmation of the mechanism of action, we demonstrated the whole-cell activity of could be fully antagonized by the addition of exogenous salicylate to the growth medium. Although the total polar surface area (tPSA) of still exceeds the nominal threshold value (140 Å) typically required for oral bioavailability, we were pleasantly surprised to observe introduction of the less acidic and conformationally constrained cinnolone moiety conferred improved drug disposition properties as evidenced by the 7-fold increase in volume of distribution in Sprague-Dawley rats.

摘要

5'-[-(水杨酰基)氨磺酰基]腺苷(Sal-AMS)是一种核苷类抗生素,它能抑制水杨酸盐掺入细菌获取铁所需的铁载体中,并且对[具体细菌名称未给出]具有强大的活性。以[具体化合物名称未给出]为代表的肉桂酮类似物被设计用来将[具体化合物名称未给出](p = 3)的酸性酰基氨磺酸盐官能团替换为更稳定的磺酰胺连接(p = 6.0),试图解决潜在的代谢问题并提高膜通透性。我们发现[具体化合物名称未给出]能有效抑制分枝杆菌水杨酸盐连接酶MbtA(表观Kd = 12 nM),阻断全细胞[具体细胞名称未给出]中水杨酸盐封端的铁载体的产生,并且在缺铁条件下表现出优异的抗分枝杆菌活性(最低抑菌浓度,MIC = 2.3 μM)。为了进一步证实作用机制,我们证明了在生长培养基中添加外源性水杨酸盐可完全拮抗[具体化合物名称未给出]的全细胞活性。尽管[具体化合物名称未给出]的总极性表面积(tPSA)仍然超过了口服生物利用度通常所需的标称阈值(140 Å),但我们惊喜地发现,引入酸性较弱且构象受限的肉桂酮部分赋予了更好的药物处置特性,这在Sprague-Dawley大鼠中的分布体积增加7倍得到了证明。

相似文献

1
Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis.构象受限的噌啉酮核苷类似物作为结核病铁载体生物合成抑制剂
ACS Med Chem Lett. 2018 Mar 16;9(4):386-391. doi: 10.1021/acsmedchemlett.8b00090. eCollection 2018 Apr 12.
2
Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.合成色酮、喹诺酮和苯并恶嗪酮磺酰胺核苷作为构象受限的抑制剂,用于抑制铁载体生物合成所需的腺苷酸酶。
J Org Chem. 2013 Aug 2;78(15):7470-81. doi: 10.1021/jo400976f. Epub 2013 Jul 12.
3
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.核苷双底物类似物对结核分枝杆菌中铁载体生物合成的抑制作用:5'-O-[N-(水杨基)氨磺酰基]腺苷碱基结构域的构效关系
J Med Chem. 2008 Sep 11;51(17):5349-70. doi: 10.1021/jm800567v. Epub 2008 Aug 9.
4
2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.5'-O-[N-(水杨基)氨磺酰基]腺苷的2-芳基-8-氮杂-3-脱氮腺苷类似物:阻断结核分枝杆菌中铁载体生物合成的核苷类抗生素。
Bioorg Med Chem. 2016 Jul 15;24(14):3133-43. doi: 10.1016/j.bmc.2016.05.037. Epub 2016 May 20.
5
Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.作为 MbtA 抑制剂和抗分枝杆菌药物的铁载体生物合成抑制剂水杨酰基-AMS 及其类似物的动力学分析。
Biochemistry. 2019 Feb 12;58(6):833-847. doi: 10.1021/acs.biochem.8b01153. Epub 2019 Jan 10.
6
Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis.用于腺苷酸化酶的基于活性的选择性探针的开发:对参与结核分枝杆菌铁载体生物合成的MbtA进行分析。
ACS Chem Biol. 2012 Oct 19;7(10):1653-8. doi: 10.1021/cb300112x. Epub 2012 Jul 23.
7
Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.结核分枝杆菌铁载体生物合成抑制剂的合成及药代动力学评价。
J Med Chem. 2015 Jul 23;58(14):5459-75. doi: 10.1021/acs.jmedchem.5b00391. Epub 2015 Jul 9.
8
5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: an adenylation enzyme required for siderophore biosynthesis of the mycobactins.5'-O-[(N-酰基)氨磺酰基]腺苷作为抑制MbtA的抗结核药物:MbtA是分枝杆菌酸铁载体生物合成所需的一种腺苷化酶。
J Med Chem. 2007 Nov 29;50(24):6080-94. doi: 10.1021/jm070905o. Epub 2007 Oct 30.
9
Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.靶向铁载体生物合成的氟化核苷抗生素的研究与构象分析。
J Org Chem. 2015 May 15;80(10):4835-50. doi: 10.1021/acs.joc.5b00550. Epub 2015 Apr 30.
10
Synthesis of deuterium-labelled 5'-O-[N-(Salicyl)sulfamoyl]adenosine (Sal-AMS-d(4)) as an internal standard for quantitation of Sal-AMS.氘标记的5'-O-[N-(水杨酰基)氨磺酰基]腺苷(Sal-AMS-d(4))的合成,作为Sal-AMS定量分析的内标。
J Labelled Comp Radiopharm. 2008 Feb;51(2):118-122. doi: 10.1002/jlcr.1490.

引用本文的文献

1
Targeting Siderophore Biosynthesis to Thwart Microbial Growth.靶向铁载体生物合成以阻止微生物生长。
Int J Mol Sci. 2025 Apr 11;26(8):3611. doi: 10.3390/ijms26083611.
2
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics.理性设计新型苯并恶唑啉合酶抑制剂:化学合成与生物学评价加速新型抗分枝杆菌抗生素的发现。
Molecules. 2023 Dec 15;28(24):8115. doi: 10.3390/molecules28248115.
3
Targeting iron-scavenging tools: a recent update on siderophores inhibitors.靶向铁清除工具:铁载体抑制剂的最新进展
RSC Med Chem. 2023 Sep 6;14(10):1885-1913. doi: 10.1039/d3md00201b. eCollection 2023 Oct 18.
4
Polyfluorinated salicylic acid analogs do not interfere with siderophore biosynthesis.多氟水杨酸类似物不会干扰铁载体生物合成。
Tuberculosis (Edinb). 2023 May;140:102346. doi: 10.1016/j.tube.2023.102346. Epub 2023 Apr 21.
5
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?铁的获取和代谢作为抗菌药物的有前途的靶点(瓶颈和机遇):我们处于什么位置?
Int J Mol Sci. 2023 Mar 24;24(7):6181. doi: 10.3390/ijms24076181.
6
Incorporation of an Isohexide Subunit Improves the Drug-like Properties of Bioactive Compounds.异山梨醇亚基的引入改善了生物活性化合物的类药物性质。
ACS Med Chem Lett. 2023 Jan 20;14(2):176-182. doi: 10.1021/acsmedchemlett.2c00476. eCollection 2023 Feb 9.
7
Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review.结核病强效杂环抑制剂的合成方法:十年回顾
Front Pharmacol. 2022 Oct 31;13:1021216. doi: 10.3389/fphar.2022.1021216. eCollection 2022.
8
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors.作为分枝杆菌生长抑制剂的嘧啶核苷类似物。
Microorganisms. 2022 Jun 27;10(7):1299. doi: 10.3390/microorganisms10071299.
9
Rational inhibitor design for Pseudomonas aeruginosa salicylate adenylation enzyme PchD.理性抑制剂设计用于铜绿假单胞菌水杨酸腺嘌呤酰化酶 PchD。
J Biol Inorg Chem. 2022 Sep;27(6):541-551. doi: 10.1007/s00775-022-01941-8. Epub 2022 May 5.
10
Advances in Key Drug Target Identification and New Drug Development for Tuberculosis.结核病关键药物靶标鉴定与新药研发进展。
Biomed Res Int. 2022 Feb 25;2022:5099312. doi: 10.1155/2022/5099312. eCollection 2022.

本文引用的文献

1
Structural analysis of the regulatory mechanism of MarR protein Rv2887 in M. tuberculosis.结核分枝杆菌 MarR 蛋白 Rv2887 调控机制的结构分析。
Sci Rep. 2017 Jul 25;7(1):6471. doi: 10.1038/s41598-017-01705-4.
2
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.结核分枝杆菌中一种杀菌化合物的N-甲基化作为耐药机制
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4523-30. doi: 10.1073/pnas.1606590113. Epub 2016 Jul 18.
3
2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.5'-O-[N-(水杨基)氨磺酰基]腺苷的2-芳基-8-氮杂-3-脱氮腺苷类似物:阻断结核分枝杆菌中铁载体生物合成的核苷类抗生素。
Bioorg Med Chem. 2016 Jul 15;24(14):3133-43. doi: 10.1016/j.bmc.2016.05.037. Epub 2016 May 20.
4
Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.结核分枝杆菌ESX-3效应蛋白在铁获取和毒力中的可分离作用。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E348-57. doi: 10.1073/pnas.1523321113. Epub 2016 Jan 4.
5
Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.结核分枝杆菌铁载体生物合成抑制剂的合成及药代动力学评价。
J Med Chem. 2015 Jul 23;58(14):5459-75. doi: 10.1021/acs.jmedchem.5b00391. Epub 2015 Jul 9.
6
Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.靶向铁载体生物合成的氟化核苷抗生素的研究与构象分析。
J Org Chem. 2015 May 15;80(10):4835-50. doi: 10.1021/acs.joc.5b00550. Epub 2015 Apr 30.
7
Lipidomic analysis links mycobactin synthase K to iron uptake and virulence in M. tuberculosis.脂质组学分析将分枝杆菌素合酶K与结核分枝杆菌的铁摄取及毒力联系起来。
PLoS Pathog. 2015 Mar 27;11(3):e1004792. doi: 10.1371/journal.ppat.1004792. eCollection 2015 Mar.
8
Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice.在小鼠体内的药代动力学和疗效研究中,分枝杆菌生物合成抑制剂水杨酰-AMS 的表现。
Antimicrob Agents Chemother. 2013 Oct;57(10):5138-40. doi: 10.1128/AAC.00918-13. Epub 2013 Jul 15.
9
Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.合成色酮、喹诺酮和苯并恶嗪酮磺酰胺核苷作为构象受限的抑制剂,用于抑制铁载体生物合成所需的腺苷酸酶。
J Org Chem. 2013 Aug 2;78(15):7470-81. doi: 10.1021/jo400976f. Epub 2013 Jul 12.
10
Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence.分枝杆菌生物合成的破坏导致结核分枝杆菌生长和毒力减弱。
J Infect Dis. 2013 Oct 15;208(8):1255-65. doi: 10.1093/infdis/jit250. Epub 2013 Jun 20.